The Gut Virome in Inflammatory Bowel Disease Pathogenesis: From Metagenomics to Novel Therapeutic Approaches

Overview

Journal United European Gastroenterol J

Publisher Wiley

Specialty Gastroenterology

Date 2019 Oct 31

PMID 31662858

Citations 31

Authors

Federica Ungaro

Luca Massimino

Silvia DAlessio

Silvio Danese

Affiliations

Soon will be listed here.

Abstract

The association of intestinal dysbiosis with the pathogenesis of inflammatory bowel disease has been well established. Besides bacteria, microbiota comprises yeasts, archaea, protists and viruses, neglected actors in inflammatory bowel disease-associated microbiota. In the past, a great limitation in studying microbiota composition was the low sensitivity of sequencing technologies and that few computational approaches were sufficient to thoroughly analyse the whole microbiome. However, new cutting-edge technologies in nucleic acid sequencing, -omics analysis and the innovative statistics and bioinformatics pipelines made possible more sensitive and accurate metagenomics, ultimately identifying novel players in intestinal inflammation, including prokaryotic and eukaryotic viruses, that together form the gut virome. The discovery of peculiar inflammatory bowel disease-associated microbial strains will not only shed new light on inflammatory bowel disease aetiogenesis, they may also support the development of novel therapeutic strategies not merely treating symptoms, but precisely counteracting the primary cause of chronic intestinal inflammation.

Citing Articles

Pathogenesis and precision medicine for predicting response in inflammatory bowel disease: advances and future directions.

Little R, Jayawardana T, Koentgen S, Zhang F, Connor S, Boussioutas A eGastroenterology. 2025; 2(1):e100006.

PMID: 39944752 PMC: 11770437. DOI: 10.1136/egastro-2023-100006.

The Role of Host Genetics and Intestinal Microbiota and Metabolome as a New Insight into IBD Pathogenesis.

Zakerska-Banaszak O, Zuraszek-Szymanska J, Eder P, Ladziak K, Slomski R, Skrzypczak-Zielinska M Int J Mol Sci. 2024; 25(17).

PMID: 39273536 PMC: 11394875. DOI: 10.3390/ijms25179589.

Integrating transcriptomics and proteomics to analyze the immune microenvironment of cytomegalovirus associated ulcerative colitis and identify relevant biomarkers.

Chen Y, Zheng Q, Wang H, Tang P, Deng L, Li P BioData Min. 2024; 17(1):26.

PMID: 39192288 PMC: 11348729. DOI: 10.1186/s13040-024-00382-0.

Predictive biomarkers for anti-TNF alpha therapy in IBD patients.

Kumar M, Murugesan S, Ibrahim N, Elawad M, Al Khodor S J Transl Med. 2024; 22(1):284.

PMID: 38493113 PMC: 10943853. DOI: 10.1186/s12967-024-05058-1.

The Inflammatory Bowel Disease Transcriptome and Metatranscriptome Meta-Analysis (IBD TaMMA) framework.

Massimino L, Lamparelli L, Houshyar Y, DAlessio S, Peyrin-Biroulet L, Vetrano S Nat Comput Sci. 2024; 1(8):511-515.

PMID: 38217242 PMC: 10766544. DOI: 10.1038/s43588-021-00114-y.

References

Stamatiades G, Ioannou P, Petrikkos G, Tsioutis C . Fungal infections in patients with inflammatory bowel disease: A systematic review. Mycoses. 2018; 61(6):366-376. PMC: 5980782. DOI: 10.1111/myc.12753. View

Sokol H, Leducq V, Aschard H, Pham H, Jegou S, Landman C . Fungal microbiota dysbiosis in IBD. Gut. 2016; 66(6):1039-1048. PMC: 5532459. DOI: 10.1136/gutjnl-2015-310746. View

Beller L, Matthijnssens J . What is (not) known about the dynamics of the human gut virome in health and disease. Curr Opin Virol. 2019; 37:52-57. DOI: 10.1016/j.coviro.2019.05.013. View

Basic M, Keubler L, Buettner M, Achard M, Breves G, Schroder B . Norovirus triggered microbiota-driven mucosal inflammation in interleukin 10-deficient mice. Inflamm Bowel Dis. 2014; 20(3):431-43. DOI: 10.1097/01.MIB.0000441346.86827.ed. View

Lin D, Lin H . A theoretical model of temperate phages as mediators of gut microbiome dysbiosis. F1000Res. 2019; 8. PMC: 6611130. DOI: 10.12688/f1000research.18480.1. View

Dethlefsen L, McFall-Ngai M, Relman D . An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature. 2007; 449(7164):811-8. PMC: 9464033. DOI: 10.1038/nature06245. View

Fernandes M, Verstraete S, Phan T, Deng X, Stekol E, LaMere B . Enteric Virome and Bacterial Microbiota in Children With Ulcerative Colitis and Crohn Disease. J Pediatr Gastroenterol Nutr. 2018; 68(1):30-36. PMC: 6310095. DOI: 10.1097/MPG.0000000000002140. View

Minot S, Bryson A, Chehoud C, Wu G, Lewis J, Bushman F . Rapid evolution of the human gut virome. Proc Natl Acad Sci U S A. 2013; 110(30):12450-5. PMC: 3725073. DOI: 10.1073/pnas.1300833110. View

Gogokhia L, Buhrke K, Bell R, Hoffman B, Brown D, Hanke-Gogokhia C . Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis. Cell Host Microbe. 2019; 25(2):285-299.e8. PMC: 6885004. DOI: 10.1016/j.chom.2019.01.008. View

10.

Cadwell K . Expanding the role of the virome: commensalism in the gut. J Virol. 2014; 89(4):1951-3. PMC: 4338900. DOI: 10.1128/JVI.02966-14. View

11.

Miquel S, Martin R, Rossi O, Bermudez-Humaran L, Chatel J, Sokol H . Faecalibacterium prausnitzii and human intestinal health. Curr Opin Microbiol. 2013; 16(3):255-61. DOI: 10.1016/j.mib.2013.06.003. View

12.

Kernbauer E, Ding Y, Cadwell K . An enteric virus can replace the beneficial function of commensal bacteria. Nature. 2014; 516(7529):94-8. PMC: 4257755. DOI: 10.1038/nature13960. View

13.

Browne H, Forster S, Anonye B, Kumar N, Neville B, Stares M . Culturing of 'unculturable' human microbiota reveals novel taxa and extensive sporulation. Nature. 2016; 533(7604):543-546. PMC: 4890681. DOI: 10.1038/nature17645. View

14.

Santiago-Rodriguez T, Hollister E . Human Virome and Disease: High-Throughput Sequencing for Virus Discovery, Identification of Phage-Bacteria Dysbiosis and Development of Therapeutic Approaches with Emphasis on the Human Gut. Viruses. 2019; 11(7). PMC: 6669467. DOI: 10.3390/v11070656. View

15.

Lim E, Zhou Y, Zhao G, Bauer I, Droit L, Ndao I . Early life dynamics of the human gut virome and bacterial microbiome in infants. Nat Med. 2015; 21(10):1228-34. PMC: 4710368. DOI: 10.1038/nm.3950. View

16.

Macfarlane G, Macfarlane S . Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics. J Clin Gastroenterol. 2011; 45 Suppl:S120-7. DOI: 10.1097/MCG.0b013e31822fecfe. View

17.

Backhed F, Roswall J, Peng Y, Feng Q, Jia H, Kovatcheva-Datchary P . Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life. Cell Host Microbe. 2015; 17(5):690-703. DOI: 10.1016/j.chom.2015.04.004. View

18.

Devkota S, Wang Y, Musch M, Leone V, Fehlner-Peach H, Nadimpalli A . Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature. 2012; 487(7405):104-8. PMC: 3393783. DOI: 10.1038/nature11225. View

19.

Sommer F, Anderson J, Bharti R, Raes J, Rosenstiel P . The resilience of the intestinal microbiota influences health and disease. Nat Rev Microbiol. 2017; 15(10):630-638. DOI: 10.1038/nrmicro.2017.58. View

20.

Garrett W, Gallini C, Yatsunenko T, Michaud M, DuBois A, Delaney M . Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe. 2010; 8(3):292-300. PMC: 2952357. DOI: 10.1016/j.chom.2010.08.004. View